| 產品名稱 |
Suid herpesvirus 1 |
| 商品貨號 |
B194494 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Pseudorabies virus |
| Agent |
Suid herpesvirus 1 |
| Common Name |
Pseudorabies virus |
| Applications |
A MOI of 0.01 is recommended for passage in Vero cells. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
USDA Strain S62/26 |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
S-PRV 001 is an attenuated TK+ virus having a deletion in both repeat sequences upstream of the promoter for the PRV immediate early genes. S PRV 001 is resistant to aminopterin. Intranasal administration to 1 day old pigs causes pseudorabies. The mutant is derived from wild-type USDA strain S62/26 (Shope). A MOI of 0.01 is recommended for passage in Vero cells. |
| Effect on Host |
Cytopathic effects in tissue culture |
| Name of Depositor |
Syntro Corporation |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
USDA Strain S62/26 |
| References |
Shih MF, et al. Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same. US Patent 4,877,737 dated Oct 31 1989
|
